Schedule 13D ownership disclosure
Invivyd Inc
Common Stock, $0.0001 par value per share · CUSIP: 00534A102
Event date: 2025-12-23
- Filing-level shares
- 20,262,170
- Percent of class
- 7.3%
- Adimab, LLCReported CIK 0001545672
Shares: 20,262,170 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-335350
- Form type
- SCHEDULE 13D/A
- Filer
- Adimab, LLC
- CIK
- CIK 1545672
- Filed
- Dec 29, 2025
- Reporting period
- Dec 23, 2025
- Description
- Schedule 13D beneficial ownership